Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hiroaki Takubo, Tomohiro Ishikawa, Olaf Kuhlmann, Hiroyuki Nemoto, Tomoyuki Noguchi, Toyomichi Nanayama, Hiroshi Komura & Motohiro Kogayu. (2014) Pharmacokinetics and disposition of dalcetrapib in rats and monkeys. Xenobiotica 44:12, pages 1117-1126.
Read now
Read now
Amit S. Kalgutkar, Kosea S. Frederick, Heather L. Hatch, Catherine M. Ambler, David A. Perry, Ravi S. Garigipati, George C. Chang, Bruce A. Lefker, Ronald W. Clark, Lee A. Morehouse, Omar Francone & Xiao Hu. (2014) Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility. Xenobiotica 44:7, pages 591-605.
Read now
Read now
Articles from other publishers (14)
Adam S. Darwich, Oliver J. Hatley, Andrés Olivares‐Morales, Farzaneh Salem, Alison Margolskee & Amin Rostami‐Hodjegan. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations
65
86
.
David Rhainds, Chris J. Packard, Mathieu R. BrodeurEric J. NiesorFrank M. Sacks, J. Wouter Jukema, R. Scott Wright, David D. Waters, Therese HeinonenDonald M. Black, Fouzia Laghrissi-Thode, Marie-Pierre Dubé, Marc A. Pfeffer & Jean-Claude Tardif. (2021) Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib. Circulation: Genomic and Precision Medicine 14:2.
Crossref
Crossref
C. Edwin Garner, Christopher J. Wegerski, Melanie Doyle-Eisele, Jacob D. McDonald, J. Michael Sanders, Benjamin C. Moeller & Suramya Waidyanatha. (2020) Disposition and metabolism of 2′,2′”-Dithiobisbenzanilide in rodents following intravenous and oral administration and dermal application. Toxicology Reports 7, pages 883-892.
Crossref
Crossref
Mathieu R. Brodeur, David Rhainds, Daniel Charpentier, Teodora Mihalache-Avram, Mélanie Mecteau, Geneviève Brand, Evelyne Chaput, Anne Perez, Eric J. Niesor, Eric Rhéaume, Cyrille Maugeais & Jean-Claude Tardif. (2017) Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys. Journal of Lipid Research 58:7, pages 1282-1291.
Crossref
Crossref
Amir Hooshang Mohammadpour & Fatemeh Akhlaghi. (2013) Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective. Clinical Pharmacokinetics 52:8, pages 615-626.
Crossref
Crossref
Mary Phelan, Judith Anzures-Cabrera, David J. Carlile, Lucy Rowell, Olaf Kuhlmann, Gerhard Arold, Richard Robson & Darren Bentley. (2013) Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib. Clinical Pharmacokinetics 52:4, pages 255-265.
Crossref
Crossref
Günter Gross, Joseph Tardio & Olaf Kuhlmann. (2012) Solubility and stability of dalcetrapib in vehicles and biological media. International Journal of Pharmaceutics 437:1-2, pages 103-109.
Crossref
Crossref
David RhaindsBenoit J ArsenaultMathieu R BrodeurJean-Claude Tardif. (2012) An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels. Future Cardiology 8:4, pages 513-531.
Crossref
Crossref
Katja Heinig, Franz Bucheli, Olaf Kuhlmann, Manfred Zell, Axel Pähler, Elke Zwanziger, Günter Gross, Joseph Tardio, Tomohiro Ishikawa & Tomoko Yamashita. (2012) Determination of dalcetrapib by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 66, pages 314-324.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Lipidology 23:2, pages 156-163.
Crossref
Crossref
D E Gutstein, R Krishna, D Johns, H K Surks, H M Dansky, S Shah, Y B Mitchel, J Arena & J A Wagner. (2011) Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction. Clinical Pharmacology & Therapeutics 91:1, pages 109-122.
Crossref
Crossref
Daniela Buchheit, Ellen I. Schmitt, Daniel Bischoff, Thomas Ebner & Matthias Bureik. (2011)
S
-Glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells
. bchm 392:12, pages 1089-1095.
Crossref
Crossref
Daniela Buchheit,Ellen I. Schmitt,Daniel Bischoff,Thomas Ebner,Matthias Bureik,. (2011) S-Glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells. Biological Chemistry, pages ---.
Crossref
Crossref
Michael Derks, Hitoshi Kawamura, Markus Abt, Georgina Meneses-Lorente, Mary Phelan & Tomohiro Ishikawa. (2011) Effects of Food Intake on the Pharmacokinetic Properties of Dalcetrapib: Findings From Three Phase I, Single-Dose Crossover Studies in Healthy Volunteers. Clinical Therapeutics 33:6, pages 754-765.
Crossref
Crossref